9th Oct 2013 12:03
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline 2009 Performance Share Plan notified the Company and the under-mentioned persons on 8 October 2013 of the following increases in their notional interests in Ordinary Shares at a price of 1571 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $50.84 per ADS following the notional re-investment of the dividend paid to shareholders on 3 October 2013.
Ordinary Shares | ADSs | |
Sir Andrew Witty | 17,855.571 | |
Dr M M Slaoui | 5,353.520 | |
Mr S Dingemans | 6,924.754 | |
Mr S M Bicknell | 1,873.095 | |
Mr R G Connor | 1,241.889 | |
Mrs D P Connelly | 2,258.480 | |
Mr S A Hussain | 5,449.411 | |
Mr W C Louv | 1,559.989 | |
Mr D S Redfern | 2,675.845 | |
Ms C Thomas | 3,719.017 | |
Mr P C Thomson | 1,180.887 | |
Mr D E Troy | 3,008.734 | |
Dr P J T Vallance | 6,159.639 | |
Ms E Walmsley | 3,497.511 | |
Mr C Weber | 872.878 | |
Mrs V A Whyte | 438.511 |
The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant measurement period.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
S M Bicknell
Company Secretary
9 October 2013
Related Shares:
Glaxosmithkline